Since currently available mouse models do not fully recapitulate human DLBCL as they lack key features, such as markers of mature B-cells, it was important to validate the benefit of combining metformin and L-asparaginase in human DLBCL patients. The gene discussed is ASPG; the disease is diffuse large B-cell lymphoma.